Literature DB >> 16912896

Age-related findings on MRI in neurofibromatosis type 1.

Deepak S Gill1, Shelley L Hyman, Adam Steinberg, Kathryn N North.   

Abstract

BACKGROUND: T2 hyperintensities (T2H) on MRI are the most common CNS lesions in individuals with neurofibromatosis type 1 (NF1).
OBJECTIVES: The aim was to determine the frequency, signal characteristics and localization of T2H at different ages. In addition, we examined the sensitivity of different MR imaging sequences in detecting these lesions.
MATERIALS AND METHODS: We studied prospectively a cohort of children, adolescents and young adults with NF1 using T2-volume (T2-V) and conventional MRI sequences. Lesions were designated as either discrete or diffuse, and the region of signal abnormality was recorded. A total of 103 patients were studied (age range 8.0-25.4 years, mean 13.9 years).
RESULTS: The frequency, size, and intensity of T2H decreased with age in the basal ganglia (BG) and the cerebellum/brainstem (CB/BS). The majority of thalamic and CB/BS lesions were diffuse. Of the total cohort, 80% had diffuse bilateral hippocampal hyperintensities and 18.4% had hemispheric lesions best demonstrated on FLAIR; there was no significant difference in the frequency or signal intensity of hemispheric lesions with age.
CONCLUSION: Lesions in the cerebral hemispheres and hippocampus imaged by MR do not change in prevalence over time, suggesting a different pathological basis from the lesions in the in BG and CB/BS that resolve with age. FLAIR and T2-V sequences are more sensitive in detecting lesions than standard T2-weighted sequences.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16912896     DOI: 10.1007/s00247-006-0267-2

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  29 in total

1.  MRI in neurofibromatosis type I: using fluid-attenuated inversion recovery pulse sequences.

Authors:  H Yamanouchi; T Kato; H Matsuda; S Takashima; N Sakuragawa; M Arima
Journal:  Pediatr Neurol       Date:  1995-05       Impact factor: 3.372

Review 2.  Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force.

Authors:  K N North; V Riccardi; C Samango-Sprouse; R Ferner; B Moore; E Legius; N Ratner; M B Denckla
Journal:  Neurology       Date:  1997-04       Impact factor: 9.910

3.  The brain in multiple neurofibromatosis (von Recklinghausen's disease): a suggested neuropathological basis for the associated mental defect.

Authors:  N P Rosman; J Pearce
Journal:  Brain       Date:  1967-12       Impact factor: 13.501

4.  Neurofibromatosis types 1 and 2: cranial MR findings.

Authors:  S Aoki; A J Barkovich; K Nishimura; B O Kjos; T Machida; P Cogen; M Edwards; D Norman
Journal:  Radiology       Date:  1989-08       Impact factor: 11.105

5.  Prospective evaluation of the brain in asymptomatic children with neurofibromatosis type 1: relationship of macrocephaly to T1 relaxation changes and structural brain abnormalities.

Authors:  R G Steen; J S Taylor; J W Langston; J O Glass; V R Brewer; W E Reddick; R Mages; E K Pivnick
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

6.  Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain.

Authors:  D P DiPaolo; R A Zimmerman; L B Rorke; E H Zackai; L T Bilaniuk; A T Yachnis
Journal:  Radiology       Date:  1995-06       Impact factor: 11.105

7.  Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders.

Authors:  K M Shannon; P O'Connell; G A Martin; D Paderanga; K Olson; P Dinndorf; F McCormick
Journal:  N Engl J Med       Date:  1994-03-03       Impact factor: 91.245

8.  Differential regulation of rasGAP and neurofibromatosis gene product activities.

Authors:  G Bollag; F McCormick
Journal:  Nature       Date:  1991-06-13       Impact factor: 49.962

9.  Identification and characterization of the neurofibromatosis type 1 protein product.

Authors:  J E DeClue; B D Cohen; D R Lowy
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

10.  Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1.

Authors:  H Terada; A J Barkovich; M S Edwards; S M Ciricillo
Journal:  AJNR Am J Neuroradiol       Date:  1996-04       Impact factor: 3.825

View more
  20 in total

Review 1.  Neuroimaging of phakomatoses: overview and advances.

Authors:  Gilbert Vézina
Journal:  Pediatr Radiol       Date:  2015-09-07

2.  Brain imaging findings and social/emotional problems in Israeli children with neurofibromatosis type 1.

Authors:  Rony Cohen; Tamar Steinberg; Liora Kornreich; Sharon Aharoni; Ayelet Halevy; Avinoam Shuper
Journal:  Eur J Pediatr       Date:  2014-07-16       Impact factor: 3.183

3.  Diffusion tensor imaging of neurofibromatosis bright objects in children with neurofibromatosis type 1.

Authors:  Gulhan Ertan; Elcin Zan; David M Yousem; Can Ceritoglu; Aylin Tekes; Andrea Poretti; Thierry A G M Huisman
Journal:  Neuroradiol J       Date:  2014-09-25

4.  Spontaneously regressing brain lesions in Smith-Lemli-Opitz syndrome.

Authors:  An N Dang Do; Eva H Baker; Katherine E Warren; Simona E Bianconi; Forbes D Porter
Journal:  Am J Med Genet A       Date:  2017-12-11       Impact factor: 2.802

Review 5.  Imaging genetics in neurodevelopmental psychopathology.

Authors:  Marieke Klein; Marjolein van Donkelaar; Ellen Verhoef; Barbara Franke
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-07       Impact factor: 3.568

6.  T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning.

Authors:  Shelley L Hyman; Deepak S Gill; Edwin Arthur Shores; Adam Steinberg; Kathryn N North
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02-13       Impact factor: 10.154

7.  Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1.

Authors:  José Roberto Lopes Ferraz Filho; Marcos Pontes Munis; Antonio Soares Souza; Rafael Angelo Sanches; Eni Maria Goloni-Bertollo; Erika Cristina Pavarino-Bertelli
Journal:  Pediatr Radiol       Date:  2008-01-30

8.  Quantitative differentiation between healthy and disordered brain matter in patients with neurofibromatosis type I using diffusion tensor imaging.

Authors:  S J P M van Engelen; L C Krab; H A Moll; A de Goede-Bolder; S M F Pluijm; C E Catsman-Berrevoets; Y Elgersma; M H Lequin
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-13       Impact factor: 3.825

9.  Reduced artefacts and improved assessment of hyperintense brain lesions with BLADE MR imaging in patients with neurofibromatosis type 1.

Authors:  Thekla von Kalle; Bernd Blank; Claudia Fabig-Moritz; Peter Müller-Abt; Michael Zieger; Katrin Wohlfarth; Peter Winkler
Journal:  Pediatr Radiol       Date:  2009-10-01

10.  Focal Areas of High Signal Intensity in Children with Neurofibromatosis Type 1: Expected Evolution on MRI.

Authors:  S Calvez; R Levy; R Calvez; C-J Roux; D Grévent; Y Purcell; K Beccaria; T Blauwblomme; J Grill; C Dufour; F Bourdeaut; F Doz; M P Robert; N Boddaert; V Dangouloff-Ros
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-13       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.